Light Clinical Trials

39 recruitingLast updated: May 21, 2026

There are 39 actively recruiting light clinical trials across 20 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3. Top locations include New York, New York, United States, Boston, Massachusetts, United States, London, United Kingdom. Updated daily from ClinicalTrials.gov.


Light Trials at a Glance

39 actively recruiting trials for light are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 15 trials, with the heaviest enrollment activity in New York, Boston, and London. Lead sponsors running light studies include Institute of Hematology & Blood Diseases Hospital, China, Nanjing University School of Medicine, and University of Alabama at Birmingham.

Browse light trials by phase

About Light Clinical Trials

Looking for clinical trials for Light? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Light trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Light clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 39 trials

Recruiting
Phase 1Phase 2

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

Immunoglobulin Light Chain (AL) Amyloidosis
AbbVie76 enrolled23 locationsNCT06158854
Recruiting
Phase 2

CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Severe Renal Impairment

Multiple Myeloma (MM)Multiple Myeloma Light Chain Induced Renal Insufficiency
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT07585760
Recruiting
Phase 1Phase 2

Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients

Systemic Light Chain Amyloidosis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.70 enrolled27 locationsNCT07266116
Recruiting
Not Applicable

Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial

PrematureInfant MalnutritionLight-For-Dates With Signs of Fetal Malnutrition+1 more
University of Alabama at Birmingham152 enrolled1 locationNCT06207071
Recruiting
Phase 1

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Relapsed or Refractory Multiple MyelomaPreviously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC180 enrolled29 locationsNCT05652335
Recruiting
Not Applicable

Peripheral Blood Flow Responses to Electromagnetic Energy

Exposure to Man-made Visible Light
University of Alabama at Birmingham40 enrolled1 locationNCT02370199
Recruiting
Phase 1Phase 2

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Relapsed/Refractory Systemic Light Chain Amyloidosis
Regeneron Pharmaceuticals220 enrolled19 locationsNCT06292780
Recruiting
Not Applicable

Light and Anesthesia

AnesthesiaSedationLight
Peking University People's Hospital66 enrolled1 locationNCT07517484
Recruiting
Not Applicable

Blue Light for Donor Site Healing in Burn Patients

Donor Site ComplicationBurnPhotobiomodulation Therapy+1 more
AUSL Romagna Rimini25 enrolled1 locationNCT07453927
Recruiting
Not Applicable

Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)

Circadian DysregulationLight ExposurePediatric Critical Illness
Laura Beth Kalvas30 enrolled1 locationNCT07384585
Recruiting
Phase 1Phase 2

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

AmyloidosisLight Chain AmyloidosisRelapsed AL Amyloidosis+1 more
Alexion Pharmaceuticals, Inc.91 enrolled18 locationsNCT07081646
Recruiting
Phase 2

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

Systemic Light Chain Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China21 enrolled1 locationNCT07151690
Recruiting
Not Applicable

Nighttime Synchrony of Your Nutrition and Circadian Health

Circadian misalignmentSleepCircadian Rhythm+8 more
University of Utah120 enrolled1 locationNCT07329283
Recruiting
Not Applicable

Light in Frail Elderly - the Effect of a Dynamic Light for Sleep and Circadian Rhythm

SleepFatigueHumans+9 more
Region Skane300 enrolled1 locationNCT05107947
Recruiting

Analysis of NfL and GFAP in Different Dietary Patterns

GFAPVegan DietVegetarian Diet+2 more
Salzburger Landeskliniken300 enrolled1 locationNCT07312994
Recruiting
Phase 2

3-Month Clinical Trial of Liquid S-PRF in Periodontal Debridement for Periodontitis Stages II-IV

Periodontitis Chronic Generalized ModeratePeriodontitisPeriodontitis (Stage 3)+6 more
Mahsa University14 enrolled1 locationNCT07293962
Recruiting
Phase 2

Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis

Primary Light-Chain Amyloidosis
Keymed Biosciences Co.Ltd90 enrolled2 locationsNCT07039578
Recruiting

Registry for Adults With Plasma Cell Disorders (PCD's)

Multiple MyelomaAmyloidosisSmoldering Multiple Myeloma+6 more
UNC Lineberger Comprehensive Cancer Center2,000 enrolled1 locationNCT03717844
Recruiting
Not Applicable

Light Therapy on Pain and Synovitis

Knee Pain ChronicLight TherapySynovitis of Knee
The Hong Kong Polytechnic University80 enrolled2 locationsNCT07057063
Recruiting

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Multiple MyelomaAcute Kidney InjuryLight Chain Nephropathy
Brigham and Women's Hospital450 enrolled1 locationNCT06483139